1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006; 295(18):2164–7.
Article
2. Reiners C, Dietlein M, Luster M. Radioiodine therapy in differentiated thyroid cancer: indications and procedures. Best Pract Res Clin Endocrinol Metab. 2008; 22(6):989–1007.
Article
3. Lee SL. Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw. 2010; 8(11):1277–86. ; quiz 87.
Article
4. Shakir MK, Krook LS, Schraml FV, Hays JH, Clyde PW. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid. 2008; 18(7):787–92.
Article
5. Krishnamurthy VR, McDougall IR. Severe hyponatremia: a danger of low-iodine diet. Thyroid. 2007; 17(9):889–92.
Article
6. Al Nozha OM, Vautour L, How J. Life-threatening hyponatremia following a low-iodine diet: a case report and review of all reported cases. Endocr Pract. 2011; 17(5):e113–7.
Article
7. Baajafer FS, Hammami MM, Mohamed GE. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism. J Endocrinol Invest. 1999; 22(1):35–9.
Article
8. Lee JE, Kim SK, Han KH, Cho MO, Yun GY, Kim KH, et al. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy. PLoS One. 2014; 9(8):): e106840.
Article
9. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg. 2003; 138(10):1055–60.
Article
10. Hirshberg B, Ben-Yehuda A. The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med. 1997; 103(4):270–3.
Article
11. Berl T, Schrier RW. Disorders of water metabolism. Schrier RW, editor. Renal and electrolyte disorders. 6th ed.Philadelphia, PA: Lippincott Williams & Wilkins;2010. p. 1–44.
12. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med. 1978; 64(4):613–21.
Article